Prato Consensus 2013

Over the last several years, substantial progress has been made in carrying colistin through procedures equivalent to modern drug development, thereby increasing understanding on how to optimise their clinical use. In view of the recent advances that have occurred, the 1st International Conference on Polymyxins was held in Prato, Italy from 2 to 4 May 2013. The overarching objective of the conference was to promote reflection, discussion and dissemination of new scientific information on the polymyxins, and thereby identify factors hampering current clinical use and set priorities for future research to inform clinical practice (R. Nation 2013)

A key aspect of the program was the identification in sessions held across the first two days of the conference of areas where gaps in knowledge still exist or where there are factors that impact the ability of clinicians to use the polymyxins safely and effectively. These topics or areas of concern were carried forward to the final session in which they were presented and discussed by a panel of experts, with active input from conference attendees from more than 27 countries. The outcome of that session is The Prato Polymyxin Consensus which summarizes high-priority areas requiring attention (R. Nation 2013, submitted for publication).


Prato Consensus Report 2013

Organizing Committee:
Roger Nation, Australia (Chair), Jian Li, Australia (Deputy Chair)
Otto Cars, Sweden, William Couet, France, Mike Dudley, USA, Bob Hancock, Canada, Johan Mouton, Netherlands, David Paterson, Australia, Vincent Tam, USA,U rsula Theuretzbacher, Austria, Brian Tsuji, USA, John Turnidge, Australia

Leave a Reply

Your email address will not be published.